Applied Molecular Transport
Latest round
- Series C
Last raised
- Sep 2019
Total raised
- $73M
Investors
- 2
About Applied Molecular Transport
Founded in 2015 and based in California, US, Applied Molecular Transport Inc. researches and develops novel oral therapeutics for severe autoimmune, inflammatory, liver, and metabolic diseases.
Who invested in Applied Molecular Transport
2 investors across 2 rounds
See all investors in Applied Molecular Transport
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Applied Molecular Transport
Who invested in Applied Molecular Transport?
Applied Molecular Transport has 2 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Applied Molecular Transport raised?
Applied Molecular Transport has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Applied Molecular Transport last raise money?
Applied Molecular Transport's most recent round on record is a Series C, in Sep 2019.
What does Applied Molecular Transport do?
Founded in 2015 and based in California, US, Applied Molecular Transport Inc.
Where is Applied Molecular Transport headquartered?
Applied Molecular Transport is headquartered in San Francisco, US.
Which VCs invest in companies like Applied Molecular Transport?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Applied Molecular Transport's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series C
Raising like Applied Molecular Transport? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.